Navigation Links
Lyncean Technologies, Inc. receives $1.1M grant from DOE to develop the Compact Light Source
Date:3/12/2013

Palo Alto-based Lyncean Technologies, Inc., today announced that it has received a $1.1M SBIR Fast-Track grant to further develop the performance of the Compact Light Source, a miniature synchrotron X-ray source employing state-of-the-art laser-beam and electron-beam technology.

The Lyncean "Compact Light Source" (CLS) has been developed to offer high-quality X ray beams, like those produced at synchrotrons, for applications that cover a broad range of X-ray science. Recently, Lyncean announced the first sale of a Compact Light Source to a biomedical imaging research center in Munich [http://www.eurekalert.org/pub_releases/2012-12/lti-lti121312.php].

During the past 30 years, synchrotron light sources have become the X-ray probe of choice for material scientists, chemists, biologists and medical researchers. With their high-quality, intense X-ray beams, these world-wide but sparse synchrotron laboratories have revolutionized X-ray science and spawned a large number of new technologies, from electronic devices to pharmaceutical drugs.

Unlike the stadium-sized synchrotron radiation sources that require a highly technical support staff, the CLS fits in a typical laboratory space and is designed to be operated directly by academic or industrial end-users. By replacing the conventional "undulator" magnets found in the large synchrotrons by laser technology, the entire device scales down in size by a factor of 200. Just like a synchrotron, the CLS makes electrons rapidly undulate, or wiggle, causing them to emit a pencil beam of nearly monochromatic X-rays which are adjustable in energy.

The Lyncean CLS is based on licensed technology from SLAC National Accelerator Laboratory. The commercial development was supported primarily by grants from the US National Institutes of Health, NIGMS and NCRR. Now that the initial commercial development is complete, the Department of Energy (DOE) through the Small Business Innovation Research Program is supporting further development of the CLS to enhance performance, and SLAC is participating as a collaborator on the grant.

Dr. Rod Loewen, Principle Investigator for the effort, explained the joint effort, "Lyncean is already at the forefront of compact light source development. By collaborating with SLAC's world-class experts in electron beam systems, we only strengthen our leadership in producing state-of-the-art X-ray sources."

"Commercialization is an important mission of DOE national labs and since the technology was a SLAC spin-off, it is natural to continue to support improvements", said Prof. Norbert Holtkamp, Associate Laboratory Director for the Accelerator Directorate at SLAC. "We want to bring SLAC's expertise to the table to build the best possible compact light source, and we are interested in the technology ourselves to be used at SLAC in the future. This is a perfect match and a tremendous opportunity."

The US National Institutes of Health provided early funding for CLS development in order to help address the growing demand of life-science users who rely on synchrotrons for structural biology research. In addition to the CLS, Lyncean has also developed X ray applications such as protein crystallography using focused beams from special X-ray optics as well as Differential Phase Contrast Imaging using the natural CLS X-ray beam directly.

Researchers, though, use a wide variety of experimental techniques when applying synchrotron radiation to their own problems. The CLS, like a large synchrotron facility, is designed to perform a breadth of X-ray applications spanning fields from biology and chemistry to nanotechnology and materials science.


'/>"/>
Contact: Rod Loewen
rod_loewen@lynceantech.com
650-320-8300 x405
Lyncean Technologies, Inc.
Source:Eurekalert

Related biology technology :

1. Palatin Technologies, Inc. to Report Fiscal Year 2012 First Quarter Results; Teleconference and Webcast to be held on November 15, 2011
2. Palatin Technologies, Inc. Reports First Quarter Fiscal Year 2012 Results; Teleconference and Webcast to be held on November 15, 2011
3. OrthoAccel® Technologies, Inc. Announces Definitive Distribution Agreement in Italy
4. Senesco Technologies, Inc. to Webcast, Live, at RetailInvestorConferences.com on December 1st
5. Animal Biotechnology - Technologies, Markets and Companies
6. Gene Therapy - Technologies, Markets and Companies
7. Biomarkers - Technologies, Markets and Companies
8. Senesco Technologies, Inc. Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com
9. Cytogenetics - Technologies, Markets and Companies
10. Cell Therapy - Technologies, Markets and Companies
11. Palatin Technologies, Inc. to Present at the 24th Annual ROTH OC Growth Stock Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/24/2020)... ... January 24, 2020 , ... The impact ... biotechnology, diagnostics, therapeutics, laboratory and clinical services during the first two decades of ... world. And as Slone Partners celebrates its 20th anniversary this year, ...
(Date:1/23/2020)... ... January 22, 2020 , ... Ideal Implant CEO ... industry at two recent North American investor forums specializing in medical advancements. New ... Technologies & Diagnostics Forum on November 21, 2019 in New York City, and ...
(Date:1/22/2020)... ... 21, 2020 , ... Microbial Discovery Group LLC (MDG) is ... and Institutional (I&I) Account Manager. Darrell will focus on servicing MDG’s partners with ... 30 years of sales experience working across multiple different market sectors such as; ...
(Date:1/22/2020)... ... January 21, 2020 , ... QCDx , a private ... a simple blood draw, today announced the sale of the proprietary RareScope™ instrument to ... will be used in clinical cancer research. , “The RareScope can detect and isolate ...
Breaking Biology Technology:
(Date:2/13/2020)... , ... February 13, 2020 , ... Murrieta Genomics ... will be hosting a lunch and learn event on February 25th from 11:30 am ... researchers and interested members of the public are invited to attend this free event, ...
(Date:2/13/2020)... ... February 13, 2020 , ... Pharmica Consulting announced ... operations executives and focusing on all facets of clinical trial planning and management. ... engagement, and more. , “We have attended the SCOPE Summit every year ...
(Date:2/11/2020)... ... 11, 2020 , ... Modality Solutions, a leading ... 9001:2015 registration by certification body Intertek. Modality Solutions’ Quality Manager, Hannah Anderson, spearheaded ... existing Standard Operating Procedures (SOPs) and created ten new SOPs. Anderson trained staff ...
Breaking Biology News(10 mins):